Innovation

Monoclonal Anti-Ubiquitinated histone H2B antibody

Yeda Research & Development Co., Ltd
posted on 08/10/2011

A novel antibody which can be used, for the first time, to recognize ubiquitinated histone 2B. This technology is novel in its ability to recognize proteins and their destinations, and may serve in diagnostics and immunoprecipitation processes.

Suggested Uses

Primary applications in research. Use as a detection tool in western blotting, immunoprecipitation and chromatin immunoprecipitation. Might be used for monitoring processes associated with modulations of ubiquitinated-H2B levels.

Innovation Details
 

Detailed Description

The invention involves the generation of antibodies specific to ubiquitinated-H2B which selectively recognize H2B when it is ubiquitinated but not H2B in its unmodified state, or ubiquitin unconjugated to H2B.

File Number: 1397 


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Shiraz Kalir at Yeda Research & Development Co., Ltd for more information.

Request more info via email request more info
People

Principal Investigator:

Moshe Oren Moshe Oren

Innovations (2)


Case Manager:

Shiraz Kalir Shiraz Kalir

Innovations (56)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

13,120 members 17,499 innovations 176 organizations

Browse

Alan Thomas, Director, UChicagoTech

"The iBridge Network has opened up new avenues for innovations at UChicagoTech. Relationships between researchers from other universities or industry can be built and strengthened, while investors can find new technologies to advance. "  read more...